Published in J Pediatr Gastroenterol Nutr on October 01, 2014
Breath analysis as a potential and non-invasive frontier in disease diagnosis: an overview. Metabolites (2015) 0.87
Classifying oxidative stress by F2-isoprostane levels across human diseases: A meta-analysis. Redox Biol (2017) 0.79
Probiotics: sorting the evidence from the myths. Med J Aust (2008) 2.21
Soluble mesothelin-related protein in an asbestos-exposed population: the dust diseases board cohort study. Am J Respir Crit Care Med (2008) 2.21
Mitochondrial DNA mutations in exhaled breath condensate of patients with lung cancer. Respir Med (2013) 2.11
Nutritional status and nutrition risk screening in hospitalized children in New Zealand. Acta Paediatr (2013) 2.09
Detection and isolation of Campylobacter species other than C. jejuni from children with Crohn's disease. J Clin Microbiol (2008) 2.06
Inflammatory bowel disease in the South Asian pediatric population of British Columbia. Am J Gastroenterol (2007) 1.88
Eosinophilic esophagitis in children with celiac disease. J Gastroenterol Hepatol (2007) 1.74
The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age. Am J Respir Crit Care Med (2012) 1.71
Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohn's disease. Inflamm Bowel Dis (2010) 1.69
NOD2/CARD15 mutation analysis and genotype-phenotype correlation in Jewish pediatric patients compared with adults with Crohn's disease. J Pediatr (2004) 1.65
Cannabis smoking and respiratory health: consideration of the literature. Respirology (2014) 1.56
Fat laden macrophages in tracheal aspirates as a marker of reflux aspiration: a negative report. J Pediatr Gastroenterol Nutr (2002) 1.56
Asbestos and the lung in the 21st century: an update. Clin Respir J (2013) 1.54
The all-age spirometry reference ranges reflect contemporary Australasian spirometry. Respirology (2011) 1.52
Biliary colic: Is it gallstones? J Paediatr Child Health (2005) 1.50
The cost of paediatric and perianal Crohn's disease in Canterbury, New Zealand. N Z Med J (2012) 1.48
Host attachment, invasion, and stimulation of proinflammatory cytokines by Campylobacter concisus and other non-Campylobacter jejuni Campylobacter species. J Infect Dis (2010) 1.48
Clinical characteristics of children with 2009 pandemic H1N1 influenza virus infections. Pediatr Int (2011) 1.47
Intestinal inflammation and impact on growth in children with cystic fibrosis. J Pediatr Gastroenterol Nutr (2015) 1.47
The effect of temperature on exhaled breath condensate collection. J Breath Res (2012) 1.45
Faecal calprotectin in suspected paediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2015) 1.45
Development and assessment of a modified Pediatric Crohn Disease Activity Index. J Pediatr Gastroenterol Nutr (2010) 1.40
Evaluation of ovarian cancer biomarkers in subjects with benign asbestos-related pleural diseases. Clin Chem Lab Med (2010) 1.39
Severe pediatric ulcerative colitis: a prospective multicenter study of outcomes and predictors of response. Gastroenterology (2010) 1.32
Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Scand J Gastroenterol (2007) 1.32
Eosinophilic pancreatitis and increased eosinophils in the pancreas. Am J Surg Pathol (2003) 1.31
Exhaled breath analysis: novel approach for early detection of lung cancer. Lung Cancer (2008) 1.28
Variation in care in pediatric Crohn disease. J Pediatr Gastroenterol Nutr (2009) 1.26
Defensins and inflammation: the role of defensins in inflammatory bowel disease. J Gastroenterol Hepatol (2009) 1.24
Steroid-resistant neutrophilic inflammation in a mouse model of an acute exacerbation of asthma. Am J Respir Cell Mol Biol (2008) 1.23
A breath test for malignant mesothelioma using an electronic nose. Eur Respir J (2011) 1.21
Isolation and detection of Campylobacter concisus from saliva of healthy individuals and patients with inflammatory bowel disease. J Clin Microbiol (2010) 1.20
Inhibition of inflammation and remodeling by roflumilast and dexamethasone in murine chronic asthma. J Pharmacol Exp Ther (2003) 1.20
Vitamin D deficiency in children with inflammatory bowel disease. Dig Dis Sci (2011) 1.18
Use of enteral nutrition for the control of intestinal inflammation in pediatric Crohn disease. J Pediatr Gastroenterol Nutr (2012) 1.17
Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children. Inflamm Bowel Dis (2008) 1.17
Exclusive enteral feeding as primary therapy for Crohn's disease in Australian children and adolescents: a feasible and effective approach. J Gastroenterol Hepatol (2006) 1.16
IBD Around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the World Digestive Health Day 2010--Inflammatory Bowel Disease Task Force meeting. Inflamm Bowel Dis (2011) 1.14
Proteomics as a method for early detection of cancer: a review of proteomics, exhaled breath condensate, and lung cancer screening. J Gen Intern Med (2008) 1.13
Update of fecal markers of inflammation in inflammatory bowel disease. J Gastroenterol Hepatol (2011) 1.13
Assay of tracheal pepsin as a marker of reflux aspiration. J Pediatr Gastroenterol Nutr (2002) 1.12
The Global Lung Initiative 2012 reference values reflect contemporary Australasian spirometry. Respirology (2012) 1.11
Microbial dysbiosis in pediatric patients with Crohn's disease. J Clin Microbiol (2012) 1.10
Tapeworm infestation: a cause of iron deficiency anemia shown by capsule endoscopy. Gastrointest Endosc (2007) 1.10
Crohn's and colitis in children and adolescents. World J Gastroenterol (2012) 1.10
Comment to: Changes of faecal microflora in patients with Crohn's disease treated with an elemental diet and total parenteral nutrition. Dig Liver Dis (2012) 1.09
Fecal calprotectin does not predict endoscopic remission in inflammatory bowel disease. Inflamm Bowel Dis (2013) 1.08
Comparison of biomarkers in exhaled breath condensate and bronchoalveolar lavage. Am J Respir Crit Care Med (2006) 1.05
Primary thoracoscopic treatment of empyema in children. J Thorac Cardiovasc Surg (2003) 1.03
Investigation of the enteric pathogenic potential of oral Campylobacter concisus strains isolated from patients with inflammatory bowel disease. PLoS One (2012) 1.03
Sponsorship, authorship, and accountability. Lancet (2002) 1.02
The pathogenic potential of Campylobacter concisus strains associated with chronic intestinal diseases. PLoS One (2011) 1.00
Long term nutritional rehabilitation by gastrostomy in Israeli patients with cystic fibrosis: clinical outcome in advanced pulmonary disease. J Pediatr Gastroenterol Nutr (2006) 1.00
Inflammatory bowel disease therapies and gut function in a colitis mouse model. Biomed Res Int (2013) 1.00
The prevalence and polymorphisms of zonula occluden toxin gene in multiple Campylobacter concisus strains isolated from saliva of patients with inflammatory bowel disease and controls. PLoS One (2013) 1.00
Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Pediatr Pulmonol (2010) 1.00
The role of azithromycin in patients with cystic fibrosis. Paediatr Respir Rev (2010) 1.00
Plasma pyridoxal-5-phosphate is inversely associated with systemic markers of inflammation in a population of U.S. adults. J Nutr (2012) 0.99
An update of the role of nutritional therapy in the management of Crohn's disease. J Gastroenterol (2012) 0.99
Use of exclusive enteral nutrition in adults with Crohn's disease: a review. World J Gastroenterol (2013) 0.99
Potential difference measurements in the lower airway of children with and without cystic fibrosis. Am J Respir Crit Care Med (2005) 0.97
Fecal S100A12: a novel noninvasive marker in children with Crohn's disease. Inflamm Bowel Dis (2006) 0.97
Crypt fission peaks early during infancy and crypt hyperplasia broadly peaks during infancy and childhood in the small intestine of humans. J Pediatr Gastroenterol Nutr (2008) 0.97
Intrinsic white-light emission from layered hybrid perovskites. J Am Chem Soc (2014) 0.96
Early cystic fibrosis lung disease detected by bronchoalveolar lavage and lung clearance index. Am J Respir Crit Care Med (2012) 0.96
Performance of serology assays for diagnosing celiac disease in a clinical setting. Clin Vaccine Immunol (2009) 0.95
Esophageal subepithelial fibrosis and hyalinization are features of eosinophilic esophagitis. J Pediatr Gastroenterol Nutr (2011) 0.95
Guidelines for the use of infant formulas to treat cows milk protein allergy: an Australian consensus panel opinion. Med J Aust (2008) 0.95
Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease. COPD (2010) 0.95
Disease activity assessment in IBD: clinical indices and biomarkers fail to predict endoscopic remission. Inflamm Bowel Dis (2015) 0.94
Local and systemic interleukin-18 and interleukin-18-binding protein in children with inflammatory bowel disease. Inflamm Bowel Dis (2008) 0.94
5-ASA and lycopene decrease the oxidative stress and inflammation induced by iron in rats with colitis. J Gastroenterol (2004) 0.93
Detection of enterohepatic and gastric helicobacter species in fecal specimens of children with Crohn's disease. Helicobacter (2008) 0.93
A receptor-targeted nanocomplex vector system optimized for respiratory gene transfer. Mol Ther (2008) 0.93
Evaluation of arm anthropometry for assessing pediatric body composition: evidence from healthy and sick children. Pediatr Res (2006) 0.92
Gastric epithelial cell CXC chemokine secretion following Helicobacter pylori infection in vitro. J Gastroenterol Hepatol (2004) 0.92
Enhanced disease severity in Helicobacter pylori-infected mice deficient in Fas signaling. Infect Immun (2002) 0.91
Assessment of nutritional status and nutritional risk in hospitalized Iranian children. Acta Paediatr (2012) 0.91